While many Northwestern students this summer might find themselves stuck in traffic commuting to their office internship, bunking in the middle of the woods at summer camp jobs or catching up with hometown friends by the beach, Communication junior Brady Meldorf is spending his break researching cults. Using funding from a Summer Undergraduate Research Grant,.
A new therapy could treat Phelan-McDermid syndrome, a rare subtype of autism spectrum disorder, according to a December study by a group of Northwestern researchers. Before the study, there was no drug or therapy specifically designed to treat patients with Phelan-McDermid syndrome. The new therapeutic drug addresses cognitive function and motor behavior deficiencies, among other.
NIH Grant to Test Shaky Treadmill in Preventing Falls With MS | Marquette University Scientists Building on Pilot Study multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.
TORONTO, ON / ACCESSWIRE / October 7, 2021 / GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) ("GHP"), a Capital Pool Company listed on the TSX Venture Exchange (the "Exchange"), is pleased to
/PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental.